Peritoneal washing cytology status as a crucial prognostic determinant in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection following preoperative chemoradiotherapy
- Takuya Yuge 1, Yasuhiro Murata 1, Daisuke Noguchi 1, Takahiro Ito 1, Aoi Hayasaki 1, Yusuke Iizawa 1, Takehiro Fujii 1, Akihiro Tanemura 1, Naohisa Kuriyama 1, Masashi Kishiwada 1, Shugo Mizuno 1
- 1Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
- 0Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Positive peritoneal washing cytology (CY+) in pancreatic cancer patients after chemoradiotherapy (CRT) indicates poor prognosis. This finding is an independent predictor of worse survival and recurrence, highlighting its clinical significance.
Area Of Science
- Oncology
- Surgical Oncology
- Gastroenterology
Background
- Prognostic implications of peritoneal washing cytology (CY) in localized pancreatic ductal adenocarcinoma (PDAC) after preoperative chemoradiotherapy (CRT) are not well-defined.
- Understanding the significance of positive CY status (CY+) is crucial for refining treatment strategies and patient counseling.
Purpose Of The Study
- To determine the prognostic significance of CY+ in localized PDAC patients undergoing resection post-CRT.
- To identify predictors associated with a positive CY status after preoperative CRT.
Main Methods
- Retrospective analysis of clinical data from 141 localized PDAC patients who underwent curative-intent resection post-CRT.
- Examination of the association between CY+ and clinicopathological factors, survival outcomes, and recurrence patterns.
Main Results
- A positive CY status (CY+) was identified in 4.3% of patients.
- CY+ patients showed higher CA19-9 levels, increased tumor location in the pancreatic body/tail, and greater anterior pancreatic capsule invasion.
- CY+ was significantly linked to higher peritoneal recurrence rates (83.3% vs. 18.5%) and shorter overall survival (OS) and recurrence-free survival (RFS).
Conclusions
- Peritoneal washing cytology is a valuable prognostic indicator in localized PDAC patients treated with preoperative CRT and resection.
- CY+ independently predicts worse OS and RFS, underscoring its importance in risk stratification.
- Factors like local invasion, poor histological response to CRT, and lack of adjuvant chemotherapy predict worse outcomes.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

